Search: onr:"swepub:oai:DiVA.org:liu-172331" >
Sodium-glucose co-t...
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology
-
- Seferovic, Petar M. (author)
- Univ Belgrade, Serbia; Serbian Acad Arts & Sci, Serbia
-
- Fragasso, Gabriele (author)
- Univ Hosp San Raffaele, Italy
-
- Petrie, Mark (author)
- Univ Glasgow, Scotland
-
show more...
-
- Mullens, Wilfried (author)
- Hasselt Univ, Belgium; Ziekenhuis Oost, Belgium
-
- Ferrari, Roberto (author)
- Univ Hosp Ferrara, Italy; Univ Hosp Ferrara, Italy; Hlth Sci Fdn, Italy
-
- Thum, Thomas (author)
- Hannover Med Sch, Germany
-
- Bauersachs, Johann (author)
- Med Sch Hannover, Germany
-
- Anker, Stefan D. (author)
- Berlin Inst Hlth, Germany; Charite Univ Med Berlin, Germany
-
- Ray, Robin (author)
- Basildon & Thurrock Univ Hosp NHS Fdn Trust, England
-
- Cavusoglu, Yuksel (author)
- Eskisehir Osmangazi Univ, Turkey
-
- Polovina, Marija (author)
- Univ Belgrade, Serbia; Clin Ctr Serbia, Serbia
-
- Metra, Marco (author)
- Univ Brescia, Italy
-
- Ambrosio, Giuseppe (author)
- Univ Perugia, Italy
-
- Prasad, Krishna (author)
- United Kingdom Med & Healthcare Prod Regulatory A, England
-
- Seferovic, Jelena (author)
- Univ Belgrade, Serbia; Clin Ctr, Serbia
-
- Jhund, Pardeep S. (author)
- Univ Glasgow, Scotland
-
- Dattilo, Giuseppe (author)
- Univ Messina, Italy
-
- Celutkiene, Jelena (author)
- Vilnius Univ, Lithuania
-
- Piepoli, Massimo (author)
- Guglielmo da Saliceto Hosp, Italy
-
- Moura, Brenda (author)
- Univ Porto, Portugal
-
- Chioncel, Ovidiu (author)
- Univ Med & Pharm Carol Davila, Romania; Emergency Inst Cardiovasc Dis Prof CC Iliescu, Romania
-
- Ben Gal, Tuvia (author)
- Tel Aviv Univ, Israel
-
- Heymans, Stefan (author)
- Maastricht Univ, Netherlands
-
- de Boer, Rudolf A. (author)
- Univ Groningen, Netherlands
-
- Jaarsma, Tiny (author)
- Linköpings universitet,Avdelningen för omvårdnad och reproduktiv hälsa,Medicinska fakulteten
-
- Hill, Loreena (author)
- Queens Univ Belfast, North Ireland
-
- Lopatin, Yuri (author)
- Volgograd State Med Univ, Russia
-
- Lyon, Alexander R. (author)
- Imperial Coll London, England; Royal Brompton Hosp, England
-
- Ponikowski, Piotr (author)
- Wroclaw Med Univ, Poland
-
- Lainscak, Mitja (author)
- Gen Hosp Murska Sobota, Slovenia; Gen Hosp Murska Sobota, Slovenia; Univ Ljubljana, Slovenia
-
- Jankowska, Ewa (author)
- Wroclaw Med Univ, Poland
-
- Mueller, Christian (author)
- Univ Hosp Basel, Switzerland
-
- Cosentino, Francesco (author)
- Karolinska Institutet
-
- Lund, Lars (author)
- Karolinska Institutet
-
- Filippatos, Gerasimos S. (author)
- Natl & Kapodistrian Univ Athens, Greece
-
- Ruschitzka, Frank (author)
- Univ Heart Ctr, Switzerland
-
- Coats, Andrew J. S. (author)
- IRCCS San Raffaele Pisana, Italy
-
- Rosano, Giuseppe M. C. (author)
- IRCCS San Raffaele Pisana, Italy
-
show less...
-
(creator_code:org_t)
- 2020-08-05
- 2020
- English.
-
In: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844. ; 22:9, s. 1495-1503
- Related links:
-
https://onlinelibrar...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Heart failure (HF) is common and associated with a poor prognosis, despite advances in treatment. Over the last decade cardiovascular outcome trials with sodium-glucose co-transporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus have demonstrated beneficial effects for three SGLT2 inhibitors (empagliflozin, canagliflozin and dapagliflozin) in reducing hospitalisations for HF. More recently, dapagliflozin reduced the risk of worsening HF or death from cardiovascular causes in patients with chronic HF with reduced left ventricular ejection fraction, with or without type 2 diabetes mellitus. A number of additional trials in HF patients with reduced and/or preserved left ventricular ejection fraction are ongoing and/or about to be reported. The present position paper summarises recent clinical trial evidence and discusses the role of SGLT2 inhibitors in the treatment of HF, pending the results of ongoing trials in different populations of patients with HF.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- Heart failure; Sodium-glucose co-transporter 2 inhibitors; Type 2 diabetes mellitus; Cardiovascular outcomes; Quality of life
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Seferovic, Petar ...
-
Fragasso, Gabrie ...
-
Petrie, Mark
-
Mullens, Wilfrie ...
-
Ferrari, Roberto
-
Thum, Thomas
-
show more...
-
Bauersachs, Joha ...
-
Anker, Stefan D.
-
Ray, Robin
-
Cavusoglu, Yukse ...
-
Polovina, Marija
-
Metra, Marco
-
Ambrosio, Giusep ...
-
Prasad, Krishna
-
Seferovic, Jelen ...
-
Jhund, Pardeep S ...
-
Dattilo, Giusepp ...
-
Celutkiene, Jele ...
-
Piepoli, Massimo
-
Moura, Brenda
-
Chioncel, Ovidiu
-
Ben Gal, Tuvia
-
Heymans, Stefan
-
de Boer, Rudolf ...
-
Jaarsma, Tiny
-
Hill, Loreena
-
Lopatin, Yuri
-
Lyon, Alexander ...
-
Ponikowski, Piot ...
-
Lainscak, Mitja
-
Jankowska, Ewa
-
Mueller, Christi ...
-
Cosentino, Franc ...
-
Lund, Lars
-
Filippatos, Gera ...
-
Ruschitzka, Fran ...
-
Coats, Andrew J. ...
-
Rosano, Giuseppe ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
European Journal ...
- By the university
-
Linköping University
-
Karolinska Institutet